Scoggin Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-225,000
Closed -$4.83M 62
2025
Q3
$4.83M Sell
225,000
-75,000
-25% -$1.68M 0.76% 28
2025
Q2
$7.7M Hold
300,000
1.6% 14
2025
Q1
$11M Buy
+300,000
New +$10.3M 3.06% 10
2023
Q2
Sell
-50,000
Closed -$1.65M 49
2023
Q1
$1.65M Sell
50,000
-37,500
-43% -$1.23M 0.97% 25
2022
Q4
$2.81M Buy
87,500
+12,500
+17% +$426K 2.27% 14
2022
Q3
$2.68M Sell
75,000
-25,000
-25% -$1.04M 1.9% 20
2022
Q2
$4.11M Hold
100,000
1.95% 16
2022
Q1
$5.79M Hold
100,000
1.56% 18
2021
Q4
$5.88M Buy
+100,000
New +$6.07M 1.67% 18

Other funds holding ATEX

Scoggin Management's ATEX Position: Q4 2025 in Review

Scoggin Management sold out of Anterix (ATEX) in Q4 2025, closing a stake of 225,000 shares — an estimated $4.83M sold.

Scoggin Management first reported a position in ATEX in Q4 2021 and held it in 9 quarters. The position peaked at $11M in Q1 2025. 117 funds tracked by Wall St. Rank hold ATEX as of Q4 2025.

  • Scoggin Management reported no remaining Anterix position as of Q4 2025 after selling out during the quarter.
  • Scoggin Management sold 225,000 Anterix shares in Q4 2025, an estimated $4.83M.
  • Scoggin Management first reported a position in Anterix in Q4 2021 and held it in 9 quarters.
  • Scoggin Management's Anterix position peaked at $11M in Q1 2025.
  • 117 funds tracked by Wall St. Rank held Anterix as of Q4 2025.

Based on Scoggin Management's 13F filing for Q4 2025, filed 17 Feb 2026.